SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity securities (PIPE). Pursuant to the securities...
Forecasting has always been central to financial planning; however, traditional methods based on historical trends are no longer enough. Economic ...
Australia is benefiting from one of the most favourable insurance market environments seen in years. However, it’s important to recognise that these...
The launch of ChatGPT in 2022 marked a turning point for AI. In three short years, AI has been integrated into everything from our phone cameras to ...
A New National Digital Publication Designed to Make Sense of Modern Australia Sydney, Australia — 26 November 2025 — Times Media Australia today an...
Ozi.com.au: The New Benchmark in Australian Digital Services In a digital landscape evolving at breakneck speed, Australian businesses are demand...
Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...